Aug 1 (Reuters) - Drugmaker Regeneron Pharmaceuticals (REGN.O), opens new tab exceeded estimates for second-quarter revenue and profit on Thursday, driven by strong demand for its top-selling eczema ...

Forbes contributors publish independent expert analyses and insights. Award winning broadcast journalist and content creator. Dry eyes and dull skin may seem like two separate beauty concerns, but ...

(Reuters) - Drugmaker Regeneron Pharmaceuticals exceeded estimates for second-quarter revenue and profit on Thursday, driven by strong demand for its top-selling eczema and eye drugs. The company has ...